Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.
This report contains market size and forecasts of Peptide Based Cancer Therapeutics in Global, including the following market information:
Global Peptide Based Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peptide Based Cancer Therapeutics market was valued at 10360 million in 2021 and is projected to reach US$ 17690 million by 2028, at a CAGR of 8.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Goserelin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide Based Cancer Therapeutics include Pfizer, AstraZeneca, Johnson & Johnson, Abbott Laboratories, Allergan, AbbVie, Bausch Health and Takeda Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide Based Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Based Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peptide Based Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
Goserelin
Bortezomib
leuprorelin
Others
Global Peptide Based Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Peptide Based Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Peptide Based Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peptide Based Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Based Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peptide Based Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Johnson & Johnson
Abbott Laboratories
Allergan
AbbVie
Bausch Health
Takeda Pharmaceutical